• Home
  • Case Study Solution

Dr. Narendran's Dilemma Custom Case Solution & Analysis

1. Evidence Brief (Case Researcher)

Financial Metrics

  • Clinic revenue growth: 15% annually (Exhibit 1).
  • Profit margin: 22% (Exhibit 2).
  • Debt-to-equity ratio: 1.4 (Exhibit 3).
  • Cost of expansion: Estimated at 12M INR for new branch (Paragraph 14).

Operational Facts

  • Current capacity: 40 patients per day at the primary location (Paragraph 3).
  • Staffing: 4 full-time nurses, 2 administrative assistants (Paragraph 5).
  • Geography: Primary operations in Chennai, India (Paragraph 1).
  • Process: Manual patient record keeping (Paragraph 8).

Stakeholder Positions

  • Dr. Narendran: Prioritizes clinical quality over rapid scale (Paragraph 12).
  • Mrs. Narendran (Business Partner): Advocates for aggressive geographic expansion (Paragraph 15).
  • Investors: Demand a 20% return on equity within 36 months (Paragraph 18).

Information Gaps

  • Customer churn rate is not documented.
  • Competitor pricing strategies in secondary markets are estimated.
  • Specific regulatory hurdles for expansion outside Chennai are not explicitly detailed.

2. Strategic Analysis (Strategic Analyst)

Core Strategic Question

How does Dr. Narendran scale operations to satisfy investor return requirements without eroding the clinical quality that defines the brand?

Structural Analysis

  • Value Chain: The primary bottleneck is the doctor-to-patient consultation time. Quality is tied to Narendran’s personal oversight.
  • Porter Five Forces: High threat of new entrants in the local medical market; low switching costs for patients; high bargaining power of specialized staff.

Strategic Options

  • Option 1: Hub-and-Spoke Model. Establish satellite clinics managed by mid-level practitioners with Narendran providing remote oversight. Trade-off: Maintains brand reach but risks dilution of clinical outcomes. Resources: 15M INR, digital diagnostic integration.
  • Option 2: Premium Boutique Expansion. Open one high-end, high-margin clinic in a secondary urban center. Trade-off: Preserves quality but fails to meet the scale required by investors. Resources: 10M INR, high-end site procurement.
  • Option 3: Digital Transformation. Invest in telemedicine and CRM systems to increase throughput at the existing clinic. Trade-off: Increases capacity without physical expansion, but requires significant cultural shift. Resources: 5M INR, software licensing, staff training.

Preliminary Recommendation

Implement Option 3 immediately to optimize current throughput, followed by a phased roll-out of Option 1 to satisfy long-term growth targets.

3. Implementation Roadmap (Implementation Specialist)

Critical Path

  • Phase 1 (Months 1-3): Deploy CRM and digitized patient files. Objective: Increase daily capacity from 40 to 55 patients.
  • Phase 2 (Months 4-9): Standardize clinical protocols for mid-level staff.
  • Phase 3 (Months 10-18): Pilot the first satellite clinic in a controlled environment.

Key Constraints

  • Talent Scarcity: Finding practitioners who meet Narendran’s clinical standards.
  • Cultural Inertia: Existing staff resistance to digital record-keeping.

Risk-Adjusted Implementation

Establish a 10% contingency budget for the digital roll-out. The primary risk is a drop in patient satisfaction during the transition; mitigate this by maintaining a concierge-style check-in process during the first 90 days.

4. Executive Review and BLUF (Executive Critic)

BLUF

Dr. Narendran must shift from a physician-centric model to a process-centric organization. The current dependence on his personal presence caps revenue and prevents exit or scale. The recommendation to combine digital throughput improvements with a satellite pilot is sound, provided he accepts that he will stop being the primary care provider for every patient. If he insists on clinical autonomy over growth, he must buy out the investors immediately to avoid a forced sale of the practice.

Dangerous Assumption

The analysis assumes that mid-level practitioners can replicate Narendran’s clinical results. This is a false premise; quality is a function of his specific expertise, not just clinical protocols.

Unaddressed Risks

  • Reputational Risk: If satellite clinics fail to meet standards, the core brand suffers permanent damage. (Probability: High; Consequence: Critical).
  • Investor Conflict: If the digital transition takes longer than 6 months, investors may trigger default clauses. (Probability: Moderate; Consequence: Severe).

Unconsidered Alternative

The practice could pivot to a high-margin specialized consultancy model, focusing on complex, high-fee cases only, rather than scaling volume.

Verdict: APPROVED FOR LEADERSHIP REVIEW.



Custom Case Solution



AI in Radiology: Scaling Healthcare Transformation at LUMC Hospital custom case study solution

Dinh's Donuts (A): Optimizing Advertising Reach custom case study solution

New Balance, GrubHub, and PepsiCo: The Politicization of Business custom case study solution

The Church Key: Unlocking Success custom case study solution

Coats: Supply Chain Challenges custom case study solution

3M Canada: The Health Care Supply Chain custom case study solution

Apple's Electric Vehicle custom case study solution

Banking Circle & EQT (A): When PE Meets Fintech for Cheaper, Faster, Cross-border Banking custom case study solution

Hengda: Realizing the Potential of the Procurement Department custom case study solution

AntChain's Blockchain as a Service: Digitising Industry Collaboration custom case study solution

Tesla's Battery Supply Chain: A Growing Concern custom case study solution

Ken Talbot - Cautionary Tale in Estate Planning custom case study solution

Marsha Simms: Trailblazer in Corporate Law custom case study solution

Domino's Pizza custom case study solution

Fast Track Derailed: The 1997 Attempt to Renew Fast Track Legislation, Abridged custom case study solution